Market Trends Akero rises on planned release of mid-stage data on liver disease assetBy admin8996erT0allJanuary 24, 2025 Rasi Bhadramani Akero Therapeutics (NASDAQ:AKRO) is up ~5% in after-hours trading Friday after announcing it will hold a conference call…
